nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—Cor pulmonale—Varenicline—nicotine dependence	0.0936	0.206	CcSEcCtD
Dasatinib—Blood calcium decreased—Varenicline—nicotine dependence	0.0248	0.0546	CcSEcCtD
Dasatinib—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0137	0.0302	CcSEcCtD
Dasatinib—Rash generalised—Varenicline—nicotine dependence	0.0133	0.0292	CcSEcCtD
Dasatinib—Myositis—Varenicline—nicotine dependence	0.0115	0.0253	CcSEcCtD
Dasatinib—Transient ischaemic attack—Varenicline—nicotine dependence	0.0112	0.0246	CcSEcCtD
Dasatinib—BMX—cardiovascular system—nicotine dependence	0.0105	0.0305	CbGeAlD
Dasatinib—STAT5B—cardiovascular system—nicotine dependence	0.00926	0.027	CbGeAlD
Dasatinib—MYT1—brain—nicotine dependence	0.00915	0.0267	CbGeAlD
Dasatinib—Cyst—Varenicline—nicotine dependence	0.00843	0.0185	CcSEcCtD
Dasatinib—Thrombosis—Varenicline—nicotine dependence	0.00796	0.0175	CcSEcCtD
Dasatinib—ZAK—cardiovascular system—nicotine dependence	0.00774	0.0226	CbGeAlD
Dasatinib—SIK3—midbrain—nicotine dependence	0.0065	0.019	CbGeAlD
Dasatinib—CSK—cardiovascular system—nicotine dependence	0.00627	0.0183	CbGeAlD
Dasatinib—EPHB1—brain—nicotine dependence	0.0061	0.0178	CbGeAlD
Dasatinib—EPHA5—midbrain—nicotine dependence	0.00592	0.0173	CbGeAlD
Dasatinib—RIPK2—cardiovascular system—nicotine dependence	0.00582	0.017	CbGeAlD
Dasatinib—Musculoskeletal pain—Varenicline—nicotine dependence	0.00571	0.0125	CcSEcCtD
Dasatinib—Pulmonary embolism—Varenicline—nicotine dependence	0.00564	0.0124	CcSEcCtD
Dasatinib—SIK2—brain—nicotine dependence	0.00539	0.0157	CbGeAlD
Dasatinib—TESK1—midbrain—nicotine dependence	0.00534	0.0156	CbGeAlD
Dasatinib—PKMYT1—brain—nicotine dependence	0.00525	0.0153	CbGeAlD
Dasatinib—Dry eye—Varenicline—nicotine dependence	0.00521	0.0114	CcSEcCtD
Dasatinib—MAPK14—cardiovascular system—nicotine dependence	0.00519	0.0151	CbGeAlD
Dasatinib—FGR—cardiovascular system—nicotine dependence	0.00517	0.0151	CbGeAlD
Dasatinib—Oesophagitis—Varenicline—nicotine dependence	0.00515	0.0113	CcSEcCtD
Dasatinib—EPHB2—brain—nicotine dependence	0.00501	0.0146	CbGeAlD
Dasatinib—STK35—midbrain—nicotine dependence	0.00493	0.0144	CbGeAlD
Dasatinib—EPHB4—cardiovascular system—nicotine dependence	0.00492	0.0143	CbGeAlD
Dasatinib—SRMS—brain—nicotine dependence	0.00491	0.0143	CbGeAlD
Dasatinib—CSK—midbrain—nicotine dependence	0.0049	0.0143	CbGeAlD
Dasatinib—JAK2—cardiovascular system—nicotine dependence	0.00488	0.0142	CbGeAlD
Dasatinib—HCK—midbrain—nicotine dependence	0.00483	0.0141	CbGeAlD
Dasatinib—EPHA2—cardiovascular system—nicotine dependence	0.00482	0.0141	CbGeAlD
Dasatinib—FYN—cardiovascular system—nicotine dependence	0.00482	0.0141	CbGeAlD
Dasatinib—EPHA8—brain—nicotine dependence	0.00481	0.014	CbGeAlD
Dasatinib—MAP3K3—cardiovascular system—nicotine dependence	0.00471	0.0137	CbGeAlD
Dasatinib—Eczema—Varenicline—nicotine dependence	0.00455	0.01	CcSEcCtD
Dasatinib—STAT5B—brain—nicotine dependence	0.00454	0.0133	CbGeAlD
Dasatinib—RIPK2—midbrain—nicotine dependence	0.00454	0.0133	CbGeAlD
Dasatinib—Libido decreased—Varenicline—nicotine dependence	0.00441	0.0097	CcSEcCtD
Dasatinib—Amnesia—Varenicline—nicotine dependence	0.00436	0.00958	CcSEcCtD
Dasatinib—ERBB3—midbrain—nicotine dependence	0.00435	0.0127	CbGeAlD
Dasatinib—Visual disturbance—Varenicline—nicotine dependence	0.00432	0.00949	CcSEcCtD
Dasatinib—Atrial fibrillation—Varenicline—nicotine dependence	0.00432	0.00949	CcSEcCtD
Dasatinib—PDGFRA—cardiovascular system—nicotine dependence	0.00426	0.0124	CbGeAlD
Dasatinib—EPHA3—brain—nicotine dependence	0.0042	0.0123	CbGeAlD
Dasatinib—SRC—cardiovascular system—nicotine dependence	0.00418	0.0122	CbGeAlD
Dasatinib—Cerebrovascular accident—Varenicline—nicotine dependence	0.00418	0.00918	CcSEcCtD
Dasatinib—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00409	0.009	CcSEcCtD
Dasatinib—SIK3—brain—nicotine dependence	0.00409	0.0119	CbGeAlD
Dasatinib—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00406	0.00893	CcSEcCtD
Dasatinib—Affect lability—Varenicline—nicotine dependence	0.00403	0.00886	CcSEcCtD
Dasatinib—MAP2K5—cardiovascular system—nicotine dependence	0.00385	0.0112	CbGeAlD
Dasatinib—EPHB4—midbrain—nicotine dependence	0.00384	0.0112	CbGeAlD
Dasatinib—ZAK—brain—nicotine dependence	0.0038	0.0111	CbGeAlD
Dasatinib—FYN—midbrain—nicotine dependence	0.00376	0.011	CbGeAlD
Dasatinib—CSF1R—cardiovascular system—nicotine dependence	0.00375	0.011	CbGeAlD
Dasatinib—Dry skin—Varenicline—nicotine dependence	0.00375	0.00825	CcSEcCtD
Dasatinib—Hypokalaemia—Varenicline—nicotine dependence	0.00372	0.00819	CcSEcCtD
Dasatinib—EPHA5—brain—nicotine dependence	0.00372	0.0108	CbGeAlD
Dasatinib—LYN—brain—nicotine dependence	0.0037	0.0108	CbGeAlD
Dasatinib—Breast disorder—Varenicline—nicotine dependence	0.0037	0.00813	CcSEcCtD
Dasatinib—MAP3K3—midbrain—nicotine dependence	0.00367	0.0107	CbGeAlD
Dasatinib—MAP4K5—midbrain—nicotine dependence	0.00367	0.0107	CbGeAlD
Dasatinib—BMPR1B—brain—nicotine dependence	0.00364	0.0106	CbGeAlD
Dasatinib—MAP3K19—brain—nicotine dependence	0.00364	0.0106	CbGeAlD
Dasatinib—BTK—brain—nicotine dependence	0.00362	0.0106	CbGeAlD
Dasatinib—Gastritis—Varenicline—nicotine dependence	0.00362	0.00796	CcSEcCtD
Dasatinib—TNK2—brain—nicotine dependence	0.00357	0.0104	CbGeAlD
Dasatinib—Abdominal distension—Varenicline—nicotine dependence	0.00356	0.00783	CcSEcCtD
Dasatinib—Dysphagia—Varenicline—nicotine dependence	0.00354	0.00778	CcSEcCtD
Dasatinib—Asthma—Varenicline—nicotine dependence	0.00354	0.00778	CcSEcCtD
Dasatinib—EPHB6—midbrain—nicotine dependence	0.00351	0.0102	CbGeAlD
Dasatinib—Angina pectoris—Varenicline—nicotine dependence	0.00344	0.00757	CcSEcCtD
Dasatinib—KIT—cardiovascular system—nicotine dependence	0.00341	0.00994	CbGeAlD
Dasatinib—YES1—midbrain—nicotine dependence	0.00339	0.0099	CbGeAlD
Dasatinib—TESK1—brain—nicotine dependence	0.00336	0.0098	CbGeAlD
Dasatinib—PDGFRB—cardiovascular system—nicotine dependence	0.00333	0.00971	CbGeAlD
Dasatinib—STK36—brain—nicotine dependence	0.0033	0.00964	CbGeAlD
Dasatinib—EPHB3—brain—nicotine dependence	0.0033	0.00964	CbGeAlD
Dasatinib—Pollakiuria—Varenicline—nicotine dependence	0.00327	0.00718	CcSEcCtD
Dasatinib—Photosensitivity reaction—Varenicline—nicotine dependence	0.00323	0.0071	CcSEcCtD
Dasatinib—Weight increased—Varenicline—nicotine dependence	0.00322	0.00708	CcSEcCtD
Dasatinib—LIMK2—brain—nicotine dependence	0.0032	0.00932	CbGeAlD
Dasatinib—Infestation—Varenicline—nicotine dependence	0.00315	0.00693	CcSEcCtD
Dasatinib—Infestation NOS—Varenicline—nicotine dependence	0.00315	0.00693	CcSEcCtD
Dasatinib—Acute coronary syndrome—Varenicline—nicotine dependence	0.00311	0.00683	CcSEcCtD
Dasatinib—STK35—brain—nicotine dependence	0.0031	0.00904	CbGeAlD
Dasatinib—Myocardial infarction—Varenicline—nicotine dependence	0.00309	0.0068	CcSEcCtD
Dasatinib—CSK—brain—nicotine dependence	0.00308	0.00898	CbGeAlD
Dasatinib—Stomatitis—Varenicline—nicotine dependence	0.00307	0.00676	CcSEcCtD
Dasatinib—Conjunctivitis—Varenicline—nicotine dependence	0.00307	0.00674	CcSEcCtD
Dasatinib—HCK—brain—nicotine dependence	0.00304	0.00886	CbGeAlD
Dasatinib—ABL2—brain—nicotine dependence	0.00302	0.00881	CbGeAlD
Dasatinib—MAP2K5—midbrain—nicotine dependence	0.003	0.00876	CbGeAlD
Dasatinib—Hepatobiliary disease—Varenicline—nicotine dependence	0.00298	0.00656	CcSEcCtD
Dasatinib—Epistaxis—Varenicline—nicotine dependence	0.00297	0.00654	CcSEcCtD
Dasatinib—ABL1—cardiovascular system—nicotine dependence	0.00297	0.00866	CbGeAlD
Dasatinib—CSF1R—midbrain—nicotine dependence	0.00293	0.00855	CbGeAlD
Dasatinib—RIPK2—brain—nicotine dependence	0.00286	0.00833	CbGeAlD
Dasatinib—Urinary tract disorder—Varenicline—nicotine dependence	0.0028	0.00615	CcSEcCtD
Dasatinib—Oedema peripheral—Varenicline—nicotine dependence	0.00279	0.00613	CcSEcCtD
Dasatinib—SIK1—brain—nicotine dependence	0.00279	0.00814	CbGeAlD
Dasatinib—Connective tissue disorder—Varenicline—nicotine dependence	0.00278	0.00612	CcSEcCtD
Dasatinib—Urethral disorder—Varenicline—nicotine dependence	0.00277	0.0061	CcSEcCtD
Dasatinib—EPHA4—brain—nicotine dependence	0.00276	0.00805	CbGeAlD
Dasatinib—ERBB3—brain—nicotine dependence	0.00273	0.00798	CbGeAlD
Dasatinib—Visual impairment—Varenicline—nicotine dependence	0.00273	0.006	CcSEcCtD
Dasatinib—MAP3K2—brain—nicotine dependence	0.00271	0.0079	CbGeAlD
Dasatinib—Erythema multiforme—Varenicline—nicotine dependence	0.00268	0.00588	CcSEcCtD
Dasatinib—KIT—midbrain—nicotine dependence	0.00266	0.00777	CbGeAlD
Dasatinib—Eye disorder—Varenicline—nicotine dependence	0.00265	0.00582	CcSEcCtD
Dasatinib—Tinnitus—Varenicline—nicotine dependence	0.00264	0.0058	CcSEcCtD
Dasatinib—Cardiac disorder—Varenicline—nicotine dependence	0.00263	0.00578	CcSEcCtD
Dasatinib—PDGFRB—midbrain—nicotine dependence	0.0026	0.00759	CbGeAlD
Dasatinib—Angiopathy—Varenicline—nicotine dependence	0.00257	0.00565	CcSEcCtD
Dasatinib—Immune system disorder—Varenicline—nicotine dependence	0.00256	0.00562	CcSEcCtD
Dasatinib—Mediastinal disorder—Varenicline—nicotine dependence	0.00255	0.00561	CcSEcCtD
Dasatinib—MAPK14—brain—nicotine dependence	0.00255	0.00743	CbGeAlD
Dasatinib—Chills—Varenicline—nicotine dependence	0.00254	0.00558	CcSEcCtD
Dasatinib—FGR—brain—nicotine dependence	0.00253	0.0074	CbGeAlD
Dasatinib—Arrhythmia—Varenicline—nicotine dependence	0.00253	0.00556	CcSEcCtD
Dasatinib—CYP1B1—cardiovascular system—nicotine dependence	0.00251	0.00733	CbGeAlD
Dasatinib—Mental disorder—Varenicline—nicotine dependence	0.00248	0.00545	CcSEcCtD
Dasatinib—Malnutrition—Varenicline—nicotine dependence	0.00246	0.00542	CcSEcCtD
Dasatinib—Erythema—Varenicline—nicotine dependence	0.00246	0.00542	CcSEcCtD
Dasatinib—FMO3—brain—nicotine dependence	0.00245	0.00714	CbGeAlD
Dasatinib—Dysgeusia—Varenicline—nicotine dependence	0.00241	0.00531	CcSEcCtD
Dasatinib—EPHB4—brain—nicotine dependence	0.00241	0.00704	CbGeAlD
Dasatinib—JAK2—brain—nicotine dependence	0.0024	0.00699	CbGeAlD
Dasatinib—Muscle spasms—Varenicline—nicotine dependence	0.00237	0.00521	CcSEcCtD
Dasatinib—EPHA2—brain—nicotine dependence	0.00237	0.00691	CbGeAlD
Dasatinib—FYN—brain—nicotine dependence	0.00236	0.00689	CbGeAlD
Dasatinib—Vision blurred—Varenicline—nicotine dependence	0.00232	0.00511	CcSEcCtD
Dasatinib—ABL1—midbrain—nicotine dependence	0.00232	0.00676	CbGeAlD
Dasatinib—MAP3K3—brain—nicotine dependence	0.00231	0.00674	CbGeAlD
Dasatinib—MAP4K5—brain—nicotine dependence	0.00231	0.00674	CbGeAlD
Dasatinib—Tremor—Varenicline—nicotine dependence	0.00231	0.00508	CcSEcCtD
Dasatinib—Ill-defined disorder—Varenicline—nicotine dependence	0.00229	0.00503	CcSEcCtD
Dasatinib—Anaemia—Varenicline—nicotine dependence	0.00228	0.00501	CcSEcCtD
Dasatinib—Malaise—Varenicline—nicotine dependence	0.00222	0.00489	CcSEcCtD
Dasatinib—Vertigo—Varenicline—nicotine dependence	0.00221	0.00487	CcSEcCtD
Dasatinib—Syncope—Varenicline—nicotine dependence	0.00221	0.00486	CcSEcCtD
Dasatinib—EPHB6—brain—nicotine dependence	0.00221	0.00644	CbGeAlD
Dasatinib—Palpitations—Varenicline—nicotine dependence	0.00218	0.00479	CcSEcCtD
Dasatinib—Loss of consciousness—Varenicline—nicotine dependence	0.00217	0.00476	CcSEcCtD
Dasatinib—Cough—Varenicline—nicotine dependence	0.00215	0.00473	CcSEcCtD
Dasatinib—Convulsion—Varenicline—nicotine dependence	0.00214	0.00469	CcSEcCtD
Dasatinib—YES1—brain—nicotine dependence	0.00213	0.00622	CbGeAlD
Dasatinib—Hypertension—Varenicline—nicotine dependence	0.00213	0.00468	CcSEcCtD
Dasatinib—Myalgia—Varenicline—nicotine dependence	0.0021	0.00461	CcSEcCtD
Dasatinib—Chest pain—Varenicline—nicotine dependence	0.0021	0.00461	CcSEcCtD
Dasatinib—Arthralgia—Varenicline—nicotine dependence	0.0021	0.00461	CcSEcCtD
Dasatinib—PDGFRA—brain—nicotine dependence	0.00209	0.0061	CbGeAlD
Dasatinib—Anxiety—Varenicline—nicotine dependence	0.00209	0.0046	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00208	0.00458	CcSEcCtD
Dasatinib—Discomfort—Varenicline—nicotine dependence	0.00207	0.00456	CcSEcCtD
Dasatinib—SRC—brain—nicotine dependence	0.00205	0.00599	CbGeAlD
Dasatinib—Oedema—Varenicline—nicotine dependence	0.00201	0.00442	CcSEcCtD
Dasatinib—Infection—Varenicline—nicotine dependence	0.002	0.00439	CcSEcCtD
Dasatinib—Shock—Varenicline—nicotine dependence	0.00198	0.00435	CcSEcCtD
Dasatinib—Nervous system disorder—Varenicline—nicotine dependence	0.00197	0.00434	CcSEcCtD
Dasatinib—Thrombocytopenia—Varenicline—nicotine dependence	0.00197	0.00433	CcSEcCtD
Dasatinib—Tachycardia—Varenicline—nicotine dependence	0.00196	0.00432	CcSEcCtD
Dasatinib—Skin disorder—Varenicline—nicotine dependence	0.00195	0.00429	CcSEcCtD
Dasatinib—Hyperhidrosis—Varenicline—nicotine dependence	0.00194	0.00427	CcSEcCtD
Dasatinib—Anorexia—Varenicline—nicotine dependence	0.00192	0.00421	CcSEcCtD
Dasatinib—MAP2K5—brain—nicotine dependence	0.00189	0.00551	CbGeAlD
Dasatinib—Hypotension—Varenicline—nicotine dependence	0.00188	0.00413	CcSEcCtD
Dasatinib—CSF1R—brain—nicotine dependence	0.00184	0.00537	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00183	0.00403	CcSEcCtD
Dasatinib—Insomnia—Varenicline—nicotine dependence	0.00182	0.004	CcSEcCtD
Dasatinib—Dyspnoea—Varenicline—nicotine dependence	0.00179	0.00394	CcSEcCtD
Dasatinib—Somnolence—Varenicline—nicotine dependence	0.00179	0.00393	CcSEcCtD
Dasatinib—Dyspepsia—Varenicline—nicotine dependence	0.00177	0.00389	CcSEcCtD
Dasatinib—Decreased appetite—Varenicline—nicotine dependence	0.00175	0.00384	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00174	0.00382	CcSEcCtD
Dasatinib—Fatigue—Varenicline—nicotine dependence	0.00173	0.00381	CcSEcCtD
Dasatinib—Constipation—Varenicline—nicotine dependence	0.00172	0.00378	CcSEcCtD
Dasatinib—Pain—Varenicline—nicotine dependence	0.00172	0.00378	CcSEcCtD
Dasatinib—KIT—brain—nicotine dependence	0.00167	0.00488	CbGeAlD
Dasatinib—Feeling abnormal—Varenicline—nicotine dependence	0.00166	0.00364	CcSEcCtD
Dasatinib—Gastrointestinal pain—Varenicline—nicotine dependence	0.00164	0.00362	CcSEcCtD
Dasatinib—PDGFRB—brain—nicotine dependence	0.00163	0.00477	CbGeAlD
Dasatinib—Urticaria—Varenicline—nicotine dependence	0.0016	0.00351	CcSEcCtD
Dasatinib—Abdominal pain—Varenicline—nicotine dependence	0.00159	0.0035	CcSEcCtD
Dasatinib—Body temperature increased—Varenicline—nicotine dependence	0.00159	0.0035	CcSEcCtD
Dasatinib—Hypersensitivity—Varenicline—nicotine dependence	0.00148	0.00326	CcSEcCtD
Dasatinib—ABCG2—midbrain—nicotine dependence	0.00146	0.00426	CbGeAlD
Dasatinib—ABL1—brain—nicotine dependence	0.00146	0.00425	CbGeAlD
Dasatinib—Asthenia—Varenicline—nicotine dependence	0.00144	0.00317	CcSEcCtD
Dasatinib—Pruritus—Varenicline—nicotine dependence	0.00142	0.00313	CcSEcCtD
Dasatinib—Diarrhoea—Varenicline—nicotine dependence	0.00138	0.00303	CcSEcCtD
Dasatinib—Dizziness—Varenicline—nicotine dependence	0.00133	0.00292	CcSEcCtD
Dasatinib—Vomiting—Varenicline—nicotine dependence	0.00128	0.00281	CcSEcCtD
Dasatinib—Rash—Varenicline—nicotine dependence	0.00127	0.00279	CcSEcCtD
Dasatinib—Dermatitis—Varenicline—nicotine dependence	0.00127	0.00279	CcSEcCtD
Dasatinib—Headache—Varenicline—nicotine dependence	0.00126	0.00277	CcSEcCtD
Dasatinib—CYP1B1—brain—nicotine dependence	0.00123	0.0036	CbGeAlD
Dasatinib—Nausea—Varenicline—nicotine dependence	0.00119	0.00263	CcSEcCtD
Dasatinib—ABCB1—cardiovascular system—nicotine dependence	0.000923	0.00269	CbGeAlD
Dasatinib—ABCG2—brain—nicotine dependence	0.000918	0.00268	CbGeAlD
Dasatinib—CYP1A1—brain—nicotine dependence	0.000872	0.00254	CbGeAlD
Dasatinib—PDGFRB—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000741	0.00366	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling by NGF—FGD1—nicotine dependence	0.000737	0.00364	CbGpPWpGaD
Dasatinib—SRC—ErbB1 downstream signaling—WASF2—nicotine dependence	0.000727	0.00359	CbGpPWpGaD
Dasatinib—ABCB1—midbrain—nicotine dependence	0.00072	0.0021	CbGeAlD
Dasatinib—SRC—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.000716	0.00354	CbGpPWpGaD
Dasatinib—LCK—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.000714	0.00353	CbGpPWpGaD
Dasatinib—FYN—Signaling by NGF—FGD1—nicotine dependence	0.000711	0.00351	CbGpPWpGaD
Dasatinib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000709	0.0035	CbGpPWpGaD
Dasatinib—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000699	0.00345	CbGpPWpGaD
Dasatinib—SRC—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.000686	0.00339	CbGpPWpGaD
Dasatinib—MAPK14—Signaling by NGF—FGD1—nicotine dependence	0.000684	0.00338	CbGpPWpGaD
Dasatinib—SRC—Signaling by VEGF—WASF2—nicotine dependence	0.000676	0.00334	CbGpPWpGaD
Dasatinib—JAK2—Signaling by NGF—FGD1—nicotine dependence	0.000676	0.00334	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000672	0.00332	CbGpPWpGaD
Dasatinib—SRMS—Immune System—WASF2—nicotine dependence	0.00067	0.00331	CbGpPWpGaD
Dasatinib—SRC—Signaling by VEGF—WASF1—nicotine dependence	0.000648	0.0032	CbGpPWpGaD
Dasatinib—SRMS—Immune System—WASF1—nicotine dependence	0.000642	0.00317	CbGpPWpGaD
Dasatinib—SRC—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.000632	0.00312	CbGpPWpGaD
Dasatinib—LCK—Signaling by NGF—FGD1—nicotine dependence	0.000592	0.00292	CbGpPWpGaD
Dasatinib—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000575	0.00284	CbGpPWpGaD
Dasatinib—TXK—Immune System—WASF2—nicotine dependence	0.00057	0.00281	CbGpPWpGaD
Dasatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000547	0.0027	CbGpPWpGaD
Dasatinib—TXK—Immune System—WASF1—nicotine dependence	0.000546	0.0027	CbGpPWpGaD
Dasatinib—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00054	0.00267	CbGpPWpGaD
Dasatinib—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000537	0.00265	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—FGD1—nicotine dependence	0.000528	0.00261	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—FGD1—nicotine dependence	0.000524	0.00259	CbGpPWpGaD
Dasatinib—BTK—Innate Immune System—WASF2—nicotine dependence	0.000514	0.00254	CbGpPWpGaD
Dasatinib—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000508	0.00251	CbGpPWpGaD
Dasatinib—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000507	0.0025	CbGpPWpGaD
Dasatinib—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0005	0.00247	CbGpPWpGaD
Dasatinib—BTK—Innate Immune System—WASF1—nicotine dependence	0.000493	0.00243	CbGpPWpGaD
Dasatinib—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000479	0.00236	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—TAS2R16—nicotine dependence	0.000474	0.00234	CbGpPWpGaD
Dasatinib—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000472	0.00233	CbGpPWpGaD
Dasatinib—HCK—Innate Immune System—WASF2—nicotine dependence	0.000472	0.00233	CbGpPWpGaD
Dasatinib—CSK—Disease—AKR1B10—nicotine dependence	0.000469	0.00232	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000466	0.0023	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TAS2R16—nicotine dependence	0.000459	0.00227	CbGpPWpGaD
Dasatinib—STAT5B—Disease—AKR1B10—nicotine dependence	0.000454	0.00224	CbGpPWpGaD
Dasatinib—ABCB1—brain—nicotine dependence	0.000453	0.00132	CbGeAlD
Dasatinib—HCK—Innate Immune System—WASF1—nicotine dependence	0.000452	0.00223	CbGpPWpGaD
Dasatinib—RIPK2—Innate Immune System—WASF2—nicotine dependence	0.000444	0.00219	CbGpPWpGaD
Dasatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000443	0.00219	CbGpPWpGaD
Dasatinib—RIPK2—Innate Immune System—WASF1—nicotine dependence	0.000426	0.0021	CbGpPWpGaD
Dasatinib—FGR—Innate Immune System—WASF2—nicotine dependence	0.000426	0.0021	CbGpPWpGaD
Dasatinib—FGR—Innate Immune System—WASF1—nicotine dependence	0.000408	0.00202	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—WASF2—nicotine dependence	0.000392	0.00193	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—WASF1—nicotine dependence	0.000375	0.00185	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—FGD1—nicotine dependence	0.000372	0.00184	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—FGD1—nicotine dependence	0.00036	0.00178	CbGpPWpGaD
Dasatinib—HCK—Disease—AKR1B10—nicotine dependence	0.00036	0.00178	CbGpPWpGaD
Dasatinib—CSK—Immune System—WASF2—nicotine dependence	0.000358	0.00177	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—WASF2—nicotine dependence	0.000347	0.00171	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000345	0.0017	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—WASF2—nicotine dependence	0.000344	0.0017	CbGpPWpGaD
Dasatinib—CSK—Immune System—WASF1—nicotine dependence	0.000343	0.00169	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TAS2R16—nicotine dependence	0.000342	0.00169	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—WASF1—nicotine dependence	0.000332	0.00164	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—WASF1—nicotine dependence	0.00033	0.00163	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—AKR1B10—nicotine dependence	0.000328	0.00162	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—WASF2—nicotine dependence	0.000328	0.00162	CbGpPWpGaD
Dasatinib—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000324	0.0016	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—AKR1B10—nicotine dependence	0.000318	0.00157	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—WASF1—nicotine dependence	0.000315	0.00155	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TAS2R16—nicotine dependence	0.000313	0.00155	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000313	0.00155	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—WASF2—nicotine dependence	0.000308	0.00152	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—WASF2—nicotine dependence	0.000307	0.00152	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000305	0.00151	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TAS2R16—nicotine dependence	0.000302	0.00149	CbGpPWpGaD
Dasatinib—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000301	0.00149	CbGpPWpGaD
Dasatinib—BTK—Immune System—WASF2—nicotine dependence	0.000299	0.00148	CbGpPWpGaD
Dasatinib—ERBB3—Disease—AKR1B10—nicotine dependence	0.000299	0.00148	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—CYP2A7—nicotine dependence	0.000296	0.00146	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—WASF1—nicotine dependence	0.000295	0.00146	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—WASF1—nicotine dependence	0.000294	0.00145	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—WASF2—nicotine dependence	0.000291	0.00144	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—CCAR1—nicotine dependence	0.000288	0.00142	CbGpPWpGaD
Dasatinib—BTK—Immune System—WASF1—nicotine dependence	0.000287	0.00142	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000283	0.0014	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—WASF1—nicotine dependence	0.000279	0.00138	CbGpPWpGaD
Dasatinib—HCK—Immune System—WASF2—nicotine dependence	0.000275	0.00136	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—FGD1—nicotine dependence	0.000271	0.00134	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—FGD1—nicotine dependence	0.000269	0.00133	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TAS2R16—nicotine dependence	0.000265	0.00131	CbGpPWpGaD
Dasatinib—HCK—Immune System—WASF1—nicotine dependence	0.000263	0.0013	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—WASF2—nicotine dependence	0.000262	0.00129	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—WASF2—nicotine dependence	0.000259	0.00128	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000258	0.00128	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—WASF2—nicotine dependence	0.000256	0.00127	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—WASF2—nicotine dependence	0.000255	0.00126	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—WASF2—nicotine dependence	0.000252	0.00125	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—WASF1—nicotine dependence	0.000251	0.00124	CbGpPWpGaD
Dasatinib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00025	0.00123	CbGpPWpGaD
Dasatinib—BLK—Immune System—WASF2—nicotine dependence	0.000249	0.00123	CbGpPWpGaD
Dasatinib—FGR—Immune System—WASF2—nicotine dependence	0.000248	0.00122	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—WASF1—nicotine dependence	0.000248	0.00122	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—FGD1—nicotine dependence	0.000246	0.00121	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—WASF1—nicotine dependence	0.000246	0.00121	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—FGD1—nicotine dependence	0.000246	0.00121	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—WASF1—nicotine dependence	0.000245	0.00121	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—WASF2—nicotine dependence	0.000243	0.0012	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—WASF1—nicotine dependence	0.000242	0.00119	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—WASF2—nicotine dependence	0.00024	0.00118	CbGpPWpGaD
Dasatinib—BLK—Immune System—WASF1—nicotine dependence	0.000239	0.00118	CbGpPWpGaD
Dasatinib—FGR—Immune System—WASF1—nicotine dependence	0.000238	0.00117	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AKR1B10—nicotine dependence	0.000237	0.00117	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—FGD1—nicotine dependence	0.000237	0.00117	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TAS2R16—nicotine dependence	0.000237	0.00117	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000236	0.00116	CbGpPWpGaD
Dasatinib—KIT—Disease—AKR1B10—nicotine dependence	0.000234	0.00116	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—WASF1—nicotine dependence	0.000233	0.00115	CbGpPWpGaD
Dasatinib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000232	0.00115	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—WASF2—nicotine dependence	0.000231	0.00114	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—WASF1—nicotine dependence	0.00023	0.00114	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—WASF2—nicotine dependence	0.000228	0.00113	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TAS2R16—nicotine dependence	0.000224	0.00111	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—WASF2—nicotine dependence	0.000224	0.00111	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—WASF1—nicotine dependence	0.000222	0.0011	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—AKR1B10—nicotine dependence	0.000222	0.0011	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—WASF1—nicotine dependence	0.000219	0.00108	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AKR1B10—nicotine dependence	0.000217	0.00107	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—WASF1—nicotine dependence	0.000215	0.00106	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—WASF2—nicotine dependence	0.00021	0.00104	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AKR1B10—nicotine dependence	0.000209	0.00103	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—FGD1—nicotine dependence	0.000208	0.00103	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—DRD2—nicotine dependence	0.000205	0.00101	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TAS2R16—nicotine dependence	0.000202	0.000997	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—WASF1—nicotine dependence	0.000201	0.000995	CbGpPWpGaD
Dasatinib—YES1—Immune System—WASF2—nicotine dependence	0.0002	0.000989	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—AKR1B10—nicotine dependence	0.0002	0.000987	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—OPRM1—nicotine dependence	0.0002	0.000986	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TAS2R16—nicotine dependence	0.000198	0.000976	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TAS2R16—nicotine dependence	0.000195	0.000961	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—OPRM1—nicotine dependence	0.000193	0.000955	CbGpPWpGaD
Dasatinib—FYN—Disease—AKR1B10—nicotine dependence	0.000193	0.000951	CbGpPWpGaD
Dasatinib—YES1—Immune System—WASF1—nicotine dependence	0.000192	0.000948	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TAS2R16—nicotine dependence	0.000187	0.000925	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—WASF2—nicotine dependence	0.000186	0.000919	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—FGD1—nicotine dependence	0.000186	0.000917	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TAS2R16—nicotine dependence	0.000185	0.000913	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AKR1B10—nicotine dependence	0.000184	0.000907	CbGpPWpGaD
Dasatinib—JAK2—Disease—AKR1B10—nicotine dependence	0.000183	0.000904	CbGpPWpGaD
Dasatinib—KIT—Immune System—WASF2—nicotine dependence	0.000179	0.000883	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—WASF1—nicotine dependence	0.000178	0.000881	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—FGD1—nicotine dependence	0.000176	0.000868	CbGpPWpGaD
Dasatinib—KIT—Immune System—WASF1—nicotine dependence	0.000171	0.000847	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—WASF2—nicotine dependence	0.000169	0.000836	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—WASF2—nicotine dependence	0.000167	0.000826	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AKR1B10—nicotine dependence	0.000164	0.00081	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—WASF1—nicotine dependence	0.000162	0.000801	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TAS2R16—nicotine dependence	0.000162	0.0008	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—WASF1—nicotine dependence	0.00016	0.000792	CbGpPWpGaD
Dasatinib—LCK—Disease—AKR1B10—nicotine dependence	0.00016	0.000792	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—FGD1—nicotine dependence	0.000158	0.000782	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AKR1B10—nicotine dependence	0.000155	0.000767	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—FGD1—nicotine dependence	0.000155	0.000766	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—WASF2—nicotine dependence	0.000153	0.000756	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—FGD1—nicotine dependence	0.000153	0.000754	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—WASF2—nicotine dependence	0.000152	0.000753	CbGpPWpGaD
Dasatinib—LYN—Immune System—WASF2—nicotine dependence	0.000149	0.000737	CbGpPWpGaD
Dasatinib—ABL1—Immune System—WASF2—nicotine dependence	0.000149	0.000734	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—WASF2—nicotine dependence	0.000147	0.000728	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—FGD1—nicotine dependence	0.000147	0.000726	CbGpPWpGaD
Dasatinib—FYN—Immune System—WASF2—nicotine dependence	0.000147	0.000726	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—WASF1—nicotine dependence	0.000147	0.000724	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—WASF1—nicotine dependence	0.000146	0.000722	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000145	0.000718	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—FGD1—nicotine dependence	0.000145	0.000717	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—OPRM1—nicotine dependence	0.000144	0.000713	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—DRD2—nicotine dependence	0.000144	0.000713	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TAS2R16—nicotine dependence	0.000143	0.000708	CbGpPWpGaD
Dasatinib—LYN—Immune System—WASF1—nicotine dependence	0.000143	0.000707	CbGpPWpGaD
Dasatinib—ABL1—Immune System—WASF1—nicotine dependence	0.000142	0.000704	CbGpPWpGaD
Dasatinib—SRC—Disease—AKR1B10—nicotine dependence	0.000142	0.000701	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—WASF2—nicotine dependence	0.000142	0.000699	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—WASF1—nicotine dependence	0.000141	0.000698	CbGpPWpGaD
Dasatinib—FYN—Immune System—WASF1—nicotine dependence	0.000141	0.000696	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AKR1B10—nicotine dependence	0.00014	0.000691	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—DRD2—nicotine dependence	0.00014	0.000691	CbGpPWpGaD
Dasatinib—JAK2—Immune System—WASF2—nicotine dependence	0.00014	0.00069	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00014	0.000689	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AKR1B10—nicotine dependence	0.000137	0.000677	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—WASF1—nicotine dependence	0.000136	0.00067	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AKR1B10—nicotine dependence	0.000135	0.000666	CbGpPWpGaD
Dasatinib—JAK2—Immune System—WASF1—nicotine dependence	0.000134	0.000661	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CYP2A7—nicotine dependence	0.000133	0.000657	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—OPRM1—nicotine dependence	0.000132	0.000652	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—OPRM1—nicotine dependence	0.000132	0.000652	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AKR1B10—nicotine dependence	0.00013	0.000641	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—WASF2—nicotine dependence	0.000129	0.000639	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AKR1B10—nicotine dependence	0.000128	0.000633	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—OPRM1—nicotine dependence	0.000127	0.000629	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FGD1—nicotine dependence	0.000127	0.000628	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—WASF1—nicotine dependence	0.000124	0.000613	CbGpPWpGaD
Dasatinib—LCK—Immune System—WASF2—nicotine dependence	0.000122	0.000604	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000121	0.000597	CbGpPWpGaD
Dasatinib—LCK—Immune System—WASF1—nicotine dependence	0.000117	0.000579	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—WASF2—nicotine dependence	0.000116	0.000571	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FGD1—nicotine dependence	0.000113	0.000556	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AKR1B10—nicotine dependence	0.000112	0.000555	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—OPRM1—nicotine dependence	0.000112	0.000552	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—WASF1—nicotine dependence	0.000111	0.000547	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—WASF2—nicotine dependence	0.000109	0.00054	CbGpPWpGaD
Dasatinib—SRC—Immune System—WASF2—nicotine dependence	0.000108	0.000535	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—DRD2—nicotine dependence	0.000105	0.000519	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—WASF1—nicotine dependence	0.000105	0.000518	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—DRD2—nicotine dependence	0.000104	0.000516	CbGpPWpGaD
Dasatinib—SRC—Immune System—WASF1—nicotine dependence	0.000104	0.000513	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—OPRM1—nicotine dependence	9.98e-05	0.000493	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKR1B10—nicotine dependence	9.94e-05	0.000491	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—WASF2—nicotine dependence	9.86e-05	0.000487	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—WASF2—nicotine dependence	9.65e-05	0.000477	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—DRD2—nicotine dependence	9.55e-05	0.000472	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—DRD2—nicotine dependence	9.54e-05	0.000471	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—WASF2—nicotine dependence	9.5e-05	0.000469	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—WASF1—nicotine dependence	9.45e-05	0.000467	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—OPRM1—nicotine dependence	9.44e-05	0.000466	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—WASF1—nicotine dependence	9.25e-05	0.000457	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—DRD2—nicotine dependence	9.2e-05	0.000454	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—WASF2—nicotine dependence	9.15e-05	0.000452	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—WASF1—nicotine dependence	9.11e-05	0.00045	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—WASF2—nicotine dependence	9.03e-05	0.000446	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—WASF1—nicotine dependence	8.77e-05	0.000433	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CYP2A7—nicotine dependence	8.66e-05	0.000428	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—WASF1—nicotine dependence	8.66e-05	0.000428	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—OPRM1—nicotine dependence	8.51e-05	0.00042	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—OPRM1—nicotine dependence	8.33e-05	0.000411	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—OPRM1—nicotine dependence	8.2e-05	0.000405	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CYP2A7—nicotine dependence	8.19e-05	0.000404	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—DRD2—nicotine dependence	8.08e-05	0.000399	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—WASF2—nicotine dependence	7.91e-05	0.000391	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—OPRM1—nicotine dependence	7.9e-05	0.00039	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—OPRM1—nicotine dependence	7.8e-05	0.000385	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—WASF1—nicotine dependence	7.58e-05	0.000375	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—DRD2—nicotine dependence	7.21e-05	0.000356	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—WASF2—nicotine dependence	7e-05	0.000346	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—DRD2—nicotine dependence	6.83e-05	0.000337	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—OPRM1—nicotine dependence	6.83e-05	0.000337	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—WASF1—nicotine dependence	6.71e-05	0.000332	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP2A7—nicotine dependence	6.54e-05	0.000323	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—DRD2—nicotine dependence	6.15e-05	0.000304	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—OPRM1—nicotine dependence	6.05e-05	0.000299	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—DRD2—nicotine dependence	6.02e-05	0.000297	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—DRD2—nicotine dependence	5.93e-05	0.000293	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—DRD2—nicotine dependence	5.71e-05	0.000282	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—DRD2—nicotine dependence	5.64e-05	0.000278	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP2A7—nicotine dependence	5.22e-05	0.000258	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD2—nicotine dependence	4.94e-05	0.000244	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD2—nicotine dependence	4.37e-05	0.000216	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	4.03e-05	0.000199	CbGpPWpGaD
